Cover Image
市場調查報告書

再生醫療的全球市場:2016∼2020年

Global Regenerative Medicine Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 321466
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
再生醫療的全球市場:2016∼2020年 Global Regenerative Medicine Market 2016-2020
出版日期: 2016年05月16日 內容資訊: 英文 117 Pages
簡介

再生醫療,是為了恢復生病的內臟器官的正常功能,再生細胞和組織,內臟器官的流程。全球再生醫療市場,預計2016∼2020年以年複合成長率20.7%擴大。

本報告提供全球再生醫療市場相關調查,市場現狀及成長預測,市場課題,各地區趨勢,以及主要供應商簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 調查方法

第4章 簡介

第5章 產品研發線

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

  • 細胞治療
  • 幹細胞研究的道德性問題
  • 全球細胞治療市場
  • 組織鷹架
  • 全球組織鷹架市場
  • 基因治療
  • 歐洲的基因治療市場

第8章 各用途市場市場區隔

  • 皮膚科
  • 肌肉骨骼
  • 眼球
  • 心血管

第9章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

第11章 促進要素的影響

第12章 市場課題

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • UniQure
  • Zimmer Biomet
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR9465

About the Regenerative Medicine Market

Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.

Technavio's analysts forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020. To calculate the market size, we used the revenue generated from the sales of various types of regenerative medicine products.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Regenerative Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • UniQure
  • Zimmer Biomet

Other Prominent Vendors

  • ACE Surgical Supply
  • Acologix
  • Advanced Biologics
  • AlloCure
  • Allosource
  • Alphatec Spine
  • Altrika
  • Amorcyte
  • Anterogen
  • Antibe Therapeutics
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen
  • Bacterin International
  • Baxter
  • Bellicum Pharmaceuticals
  • BioCardia
  • Biogen Idec
  • BioRestorative Therapies
  • Biostage Technologies
  • Bluebird Bio
  • BONESUPPORT
  • BrainStorm Cell Therapeutics
  • Caladrius Biosciences
  • Calimmune
  • Capricor Therapeutics
  • Celgene
  • Cell Medica
  • CellSeed
  • Cell Therapy
  • Celyad
  • CESCA THERAPEUTICS
  • CRC for Cell Therapy Manufacturing
  • Cryolife
  • Cynata Therapeutics
  • Cytori Therapeutics
  • Dendreon
  • DiscGenics
  • Fate Therapeutics
  • Fibrocell Science
  • Forticell Bioscience
  • Fortress Biotech
  • FUJIFILM
  • Gamida Cell
  • Geron
  • GlaxoSmithKline
  • Healthpoint
  • Histogen
  • Histogenics
  • Holostem Terapie Avanzate
  • Humacyte
  • ImmunoCellular Therapeutics
  • Integra LifeSciences
  • Intercytex
  • InVivo Therapeutics
  • iSTO Technologies
  • Janssen Pharma
  • Juno Therapeutics
  • Juventas Therapeutics
  • Kensey Nash
  • Kiadis Pharma
  • Kinetic Concept
  • LifeCell
  • LifeNet Health
  • Living Cell Technologies
  • Lonza
  • MaxCyte
  • MEDIPOST
  • Mesoblast
  • Nanofiber Solutions CTO
  • Nanotope
  • NeoStem
  • Neuralstem
  • Newlink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • Ocata Therapeutics
  • Opexa Therapeutics
  • Organovo Holdings
  • Orteg
  • Orthofix
  • Osiris Therapeutics
  • Osteotech
  • Pfizer
  • Pharmicell
  • Pluristem Therapeutics
  • Prima BioMed
  • Q Therapeutics
  • Regenerex
  • Regenerys
  • Regience
  • Regrow
  • Replicel
  • ReproCELL
  • Renova Therapeutics
  • RhinoCyte
  • Rohto Pharmaceutical
  • RTI Surgical
  • SanBio
  • Sangamo BioSciences
  • Shanghai Sunway Biotech
  • Shire Regenerative Medicine
  • StemCells
  • Stratech
  • Takara Bio
  • TEI Biosciences
  • tella
  • Tengion
  • Tissue Genesis
  • TissueGene
  • Txcell
  • VentriNova
  • Vericel
  • ViaCyte
  • Vistagen
  • Market driver
  • Increased focus on cell therapy products
  • For a full, detailed list, view our report

Market challenge

  • High cost and failure rate in clinical trials
  • For a full, detailed list, view our report

Market trend

  • Increased number of regenerative medicine in product line
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Pipeline portfolio

  • Pipeline analysis

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product

  • Cell therapy
  • Ethical issues of stem cell research
  • Global cell therapy market
  • Tissue scaffold
  • Global tissue scaffold market
  • Gene therapy
  • Gene therapy market in Europe

PART 08: Market segmentation by application

  • Dermatology
  • Musculoskeletal
  • Ocular
  • Cardiovascular

PART 09: Geographical segmentation

  • Regenerative medicine market in Americas
  • Regenerative medicine market in EMEA
  • Regenerative medicine market in APAC

PART 10: Market drivers

  • Increased prevalence of chronic diseases
  • Funding by governments in regenerative medicine
  • Increased focus on cell therapy products
  • Technological innovations

PART 11: Impact of drivers

PART 12: Market challenges

  • Stringent regulatory standards impeding product approvals
  • Ethical challenges in stem cell research
  • High cost and failure rate in clinical trials

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Increase in strategic alliances
  • Increased number of regenerative medicine in the pipeline
  • Gene therapy trending toward geographic expansion

PART 15: Vendor landscape

  • Competitive scenario
  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • UniQure
  • Zimmer Biomet
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Overview of key sectors involved in regenerative medicine
  • Exhibit 03: Key sectors in regenerative medicine 2015
  • Exhibit 04: SBIR and STTR programs
  • Exhibit 05: Clinical trials 2014
  • Exhibit 06: Number of clinical trials and products in regenerative medicine market 2014
  • Exhibit 07: Pipeline of regenerative medicines for CVDs
  • Exhibit 08: Pipeline of regenerative medicines for central nervous system, orthopedic, and ocular disorders
  • Exhibit 09: Pipeline of regenerative medicines for dermatology and diabetes
  • Exhibit 10: Pipeline of regenerative medicines for oncology
  • Exhibit 11: Global regenerative medicine market 2015-2020 ($ billions)
  • Exhibit 12: Five forces analysis
  • Exhibit 13: Global regenerative medicine market by product
  • Exhibit 14: Global regenerative medicine market by product 2015
  • Exhibit 15: Cell therapy: Overview
  • Exhibit 16: Ethical issues faced in different cell therapy research category
  • Exhibit 17: Stem cell research policies in emerging countries in Americas
  • Exhibit 18: Stem cell research policies in EMEA
  • Exhibit 19: Stem cell research policies in APAC
  • Exhibit 20: Key cell therapy products marketed in the US
  • Exhibit 21: Key cell therapy products marketed in EMEA
  • Exhibit 22: Key marketed cell therapy products in APAC
  • Exhibit 23: Opportunity analysis of cell therapy in global regenerative medicine market
  • Exhibit 25: Collaborations for R&D of tissue scaffold
  • Exhibit 26: Opportunity analysis of tissue scaffold in regenerative medicine market
  • Exhibit 27: Global tissue scaffold market 2015-2020 ($ billions)
  • Exhibit 28: Recent M&A in tissue scaffold market
  • Exhibit 29: Gene therapy products in Europe
  • Exhibit 30: Opportunity analysis of gene therapy in global regenerative medicine market
  • Exhibit 31: Gene therapy market in Europe 2015-2020 ($ billions)
  • Exhibit 32: European Commission support in gene transfer and gene therapy projects
  • Exhibit 33: Global regenerative medicine market by application
  • Exhibit 34: Global regenerative medicine market by application 2015
  • Exhibit 35: Overview of dermatology segment in global regenerative medicine market
  • Exhibit 36: Pipeline of regenerative medicine for dermatology
  • Exhibit 37: Overview of musculoskeletal segment in global regenerative medicine market
  • Exhibit 38: Overview of ocular segment in global regenerative medicine market
  • Exhibit 39: Overview of cardiovascular segment in global regenerative medicine market
  • Exhibit 40: Global regenerative medicine market by geography 2015
  • Exhibit 41: Global regenerative medicine market by geography 2020
  • Exhibit 42: Funding by federal agencies for R&D of regenerative medicine 2014 ($ millions)
  • Exhibit 43: Regenerative medicine market in Americas 2015-2020 ($ billions)
  • Exhibit 44: Distribution of 45 cell therapy vendors in Europe 2011
  • Exhibit 45: Regenerative medicine market in EMEA 2015-2020 ($ billions)
  • Exhibit 46: Regenerative medicine market in APAC 2015-2020 ($ billions)
  • Exhibit 47: Key developments in regenerative medicine market in Japan 2015
  • Exhibit 48: Global regenerative medicine market by geography 2015-2020
  • Exhibit 49: Global regenerative medicine market by geography 2015-2020 ($ billions)
  • Exhibit 50: Breakdown of CIRM funding in various stem cell research studies 2014 ($ billions)
  • Exhibit 51: Active programs under CIRM 2014
  • Exhibit 52: Funding by European Commission for regenerative medicine
  • Exhibit 53: Impact of drivers
  • Exhibit 54: Impact of drivers and challenges
  • Exhibit 55: Major strategic alliances in global regenerative medicine market
  • Exhibit 56: Mid- and late-stage pipeline products for regenerative medicine
  • Exhibit 57: Clinical trials on gene therapy for various indications
  • Exhibit 58: Vendors in global regenerative medicine market
  • Exhibit 59: Acelity: Business segmentation by revenue 2015
  • Exhibit 60: Acelity: Regenerative medicine revenues and YoY growth rate 2013-2015 ($ millions)
  • Exhibit 61: Acelity: Metrics analysis
  • Exhibit 62: Medtronic: Metrics analysis
  • Exhibit 63: MiMedx Group: Metrics analysis
  • Exhibit 64: Organogenesis: Metrics analysis
  • Exhibit 65: UniQure: Metrics analysis
  • Exhibit 66: Zimmer Biomet: Metrics analysis
  • Exhibit 67: Other prominent vendors
Back to Top